Back

Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.

30 August 2016 (16:03 - 16:10)
Organised by:
Congress Presentation Part of: Valve repair and assist devices Aortic Disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Katarzyna Czerwinska-Jelonkiewicz

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis
Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery
Doctor T. Wang (Cleveland, US)
Abstract Slides
Presentation thumbnail
Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation
Mr G. Martin (Manchester, GB)
Abstract Slides
Presentation thumbnail
Metabolic syndrome affects valve-related adverse events after biological heart valve replacement
Doctor E. Angeloni (Rome, IT)
Abstract Slides
Presentation thumbnail
Preservation of arterial pulsatility to prevent acquired von willebrand disease with continuous-flow left ventricular assist device : insights from a pig model
Doctor F. Vincent (Lille, FR)
Abstract

Access the full session

Session thumbnail
Valve repair and assist devices

The Event

Event poster

ESC Congress 2016

30 August 2016 16:03 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources